CanSino's inhaled Covid-19 vaccine gets emergency use approval in China

INSUBCONTINENT EXCLUSIVE:
HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug
regulator for emergency use as a booster, potentially benefiting its business.